Meta-Analysis of VTE Risk: Ovarian Cancer Patients by Stage, Histology, Cytoreduction, and Ascites at Diagnosis

Figure 5

Forest plot of the odds of VTE in ovarian cancer patients that have complete cytoreduction surgery with no tumor mass left (versus incomplete cytoreduction with tumor mass left). This figure shows the pooled odd of complete cytoreduction (versus incomplete cytoreduction). The total pooled odds are 1.05 (0.27–4.11).